Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF (ARCA: PBE)
Financials · Capital Markets · US
$93.74
+1.06% today · +38.5% 1Y
Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF (ARCA: PBE) operates in the Capital Markets industry within the Financials sector. The company is valued at $382.48M.
Over the last twelve months the share price has gained 38.5%, trading between 64.78 and 94.06.
Tweenvest scores Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF across four factors: quality 36/100, value 32/100, dividend 7/100. Its strongest factor is quality.
PBE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $382.48M
- Revenue (TTM)
- $1.72M
- P/E
- 5.03
- EPS
- 18.65
- Dividend yield
- 0.92%
- Beta (5Y)
- 0.70
- 52-week high
- $94.06
- 52-week low
- $64.78
- Avg volume (3M)
- —
- Shares outstanding
- 4.08M
- Employees
- —
- Next earnings
- —
About Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF
The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation. It consists of 30 U.S.-based companies within the biotechnology and genome sectors. These companies are primarily involved in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, or they are businesses that stand to gain significantly from scientific and technological breakthroughs in biotechnology and genetic engineering. Both the ETF and its benchmark index undergo quarterly rebalancing and reconstitution in February, May, August, and November.
- ISIN
- US46137V7872
- Founded
- 2005
- Listed since
- Jun 23, 2005
- Exchange
- NYSE Arca
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.31T | $378.24 | +0.44% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $703.71 | +0.39% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $893.67B | $769.31 | +0.39% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $821.60B | $765.72 | +0.41% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $487.14B | $713.44 | +0.36% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $378.44B | $87.50 | +0.38% |
| Morgan StanleyNYSE: MS | $336.42B | $214.20 | +3.25% |
| The Goldman Sachs Group, Inc.NYSE: GS | $314.66B | $1,039.28 | +3.73% |
Figures last refreshed Aug 18, 2026.